NGS: (Next-generation sequencing) also known as high-throughput sequencing, is the catch-all term used to illustrate a number of different modern sequencing technologies including: Illumina (Solexa) sequencing. Roche 454 sequencing. Ion torrent: Proton / PGM sequencing.
-
This webinar offers a unique opportunity to hear directly from Professor Mathias Uhlén, lead author of the recent Science publication introducing the human pan-disease blood atlas. Bu...
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sam...
DNA fragmentation is a crucial first step in Next Generation Sequencing (NGS) workflows—from Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) to ChIP-seq and Minimal Resi...
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
Hereditary cancer risk assessment is a rapidly advancing field, driven by the need for comprehensive variant detection, streamlined genomic workflows, and alignment with evolving guidelines....
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
For too long, researchers have relied on outdated purification techniques. It's time for a change. BioEcho, now part of Admera, offers a revolutionary approach to nucleic acid purificati...
LGC offers a comprehensive portfolio of reference standards and scientific tools for a wide range of disciplines. The focus of this talk will be on reference materials for clinical NGS produ...
MAY 13, 2025 | 8:15 AM
C.E. CREDITS
Webinar 2 will focus on specimen types, specimen management, extraction, quantification, and various types of library preparation (amplicon vs. hybrid capture) for DNA. We will also include...
APR 24, 2025 | 1:00 AM
C.E. CREDITS
Isothermal amplification methods streamline nucleic acid amplification without the need for thermal cycling. Join us to explore two innovative techniques, Recombinase Polymerase Amplificatio...
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
This session provides an introduction to the MiSeq i100 Series, the simplest, fastest benchtop sequencer. Giving a brief overview of the revolutionary technology that's been built into the n...
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
Early detection is critical in combating invasive fungal and mold infections, where every moment counts. Traditional culture-based methods often fall short, with lengthy turnaround times and...
JAN 29, 2025 | 8:15 AM
C.E. CREDITS
Webinar 2 will focus on specimen types, specimen management, extraction, quantification, and various types of library preparation (amplicon vs. hybrid capture) for DNA. We will also include...
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP). Gene editing is used to introduce single nucle...
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective...
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants – especially when workflows include target enrichment, which foc...
OCT 17, 2024 | 8:15 AM
C.E. CREDITS
In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, C...
Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer...